These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review. Ratjen F; Brockhaus F; Angyalosi G J Cyst Fibros; 2009 Dec; 8(6):361-9. PubMed ID: 19747887 [TBL] [Abstract][Full Text] [Related]
5. The approach to Pseudomonas aeruginosa in cystic fibrosis. Bendiak GN; Ratjen F Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546 [TBL] [Abstract][Full Text] [Related]
6. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis. Lahiri T Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment. Zabner R; Quinn JP Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544 [TBL] [Abstract][Full Text] [Related]
8. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Greally P; Whitaker P; Peckham D Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602 [TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis infections: treatment strategies and prospects. George AM; Jones PM; Middleton PG FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113 [TBL] [Abstract][Full Text] [Related]
10. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway. Fick RB; Sonoda F; Hornick DB Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. Møller NE; Høiby N Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884 [TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Murray TS; Egan M; Kazmierczak BI Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667 [TBL] [Abstract][Full Text] [Related]
13. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure. Hayes D; Kanga JF; Anstead MI; Kuhn RJ Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis. Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432 [No Abstract] [Full Text] [Related]
15. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?]. Hubert D; Desmazes-Dufeu N; Dusser D Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145 [No Abstract] [Full Text] [Related]
16. Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine. Elborn JS; Henig NR Expert Opin Pharmacother; 2010 Jun; 11(8):1373-85. PubMed ID: 20426707 [TBL] [Abstract][Full Text] [Related]
17. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms. Bosso JA; Mauldin PD; Steed LL Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687 [TBL] [Abstract][Full Text] [Related]
18. Eradication of early Pseudomonas aeruginosa infection. Høiby N; Frederiksen B; Pressler T J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416 [TBL] [Abstract][Full Text] [Related]
19. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients. Rao P; McCaughan J; McCalmont M; Goldsmith CE; Hall V; Millar BC; McCann MA; Downey DG; Rendall JC; Elborn JS; Moore JE J Cyst Fibros; 2012 Jul; 11(4):349-52. PubMed ID: 22325689 [No Abstract] [Full Text] [Related]
20. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]